FDA warns consumers to avoid fraudulent Ebola treatment products

Aug. 18, 2014

The agency said that it had seen and received consumer complaints about various products being offered online that are claimed to either prevent the Ebola virus or treat the infection.

The U.S. Food and Drug Administration (FDA) is warning consumers about fraudulent Ebola treatment products being offered for sale.

In an announcement issued on Thursday, the agency said that it had seen and received consumer complaints about various products being offered online that are claimed to either prevent the Ebola virus or treat the infection.

This comes after an outbreak of the Ebola virus in West Africa.

The FDA noted that, while there are experimental Ebola vaccines and treatments under development, these investigational products are in the early stages of product development. They have not yet been fully tested for safety or effectiveness, and there is only a very limited supply.

As yet there are no FDA-approved vaccines, drugs or investigational products to prevent or treat Ebola. Moreover, dietary supplements are not allowed to be offered alongside claims that they can prevent or cure disease.

The FDA sought to reassure the public by noting that, according to the Centers for Disease Control and Prevention (CDC), Ebola does not pose a significant risk to the general public in the United States. It said that when an outbreak occurs it is common to see fraudulent products that claim to prevent, treat or cure a disease appearing on the market.

As part of its work the FDA monitors for such fraudulent products and false claims and takes appropriate action to protect consumers.

Ebola is the cause of a viral hemorrhagic fever disease. In the United States, Ebola is not a water-borne or food-borne illness and is not transmitted through the air. It is spread through direct contact with the body fluids of an infected person, or with objects such as needles that have been contaminated with the virus, the FDA said.

Sponsored Recommendations

Choosing The Right Partner for CHIPS Act Investments

As the U.S. looks to invest in the semiconductor research and production using CHIPS Act 2022 funding, it's important to choose the right partner.

EMWD Uses Technology to Meet Sustainability Goals

Eastern Municipal Water District pilots artificial intelligence-enabled control and machine learning to help save energy, reduce costs, and improve quality.

Protein Processing Solutions: Automation & Control

For protein processors looking to address industry challenges, improve efficiency, and stay ahead in a competitive market, Rockwell Automation offers tailored automation, control...

Automotive Manufacturing Innovation: Smart Solutions for a Connected Future

Rockwell Automation provides automation and control systems tailored for the automotive and tire industries, supporting electric vehicle production, tire production, battery production...